M&T Bank Corp Has $100.44 Million Holdings in Danaher Corporation $DHR

M&T Bank Corp increased its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 1.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 438,768 shares of the conglomerate’s stock after buying an additional 5,985 shares during the quarter. M&T Bank Corp’s holdings in Danaher were worth $100,443,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in DHR. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth $26,000. Elevated Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter worth $27,000. Finally, Financial Life Planners acquired a new stake in Danaher during the 3rd quarter worth $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 10.80% of the company’s stock.

Danaher Trading Up 0.1%

Danaher stock opened at $175.30 on Monday. Danaher Corporation has a 52 week low of $174.60 and a 52 week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a market capitalization of $124.07 billion, a P/E ratio of 33.91, a PEG ratio of 2.34 and a beta of 0.81. The stock has a 50-day simple moving average of $193.34 and a 200 day simple moving average of $213.25.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the company posted $1.88 earnings per share. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. Analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Friday, March 27th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. Leerink Partners raised their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a research note on Tuesday, April 21st. Wells Fargo & Company dropped their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Evercore lifted their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Eighteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $240.70.

Check Out Our Latest Research Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.